Hetzer Medical Indonesia Tbk. vs Sarimelati Kencana Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp73 (market cap 109.38B, 60.43M 24h volume), while Sarimelati Kencana Tbk. trades at Rp182 (market cap 549.98B, 336.9K 24h volume). The key difference: Sarimelati Kencana Tbk. is far larger — about 5× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (60.43M versus 336.9K). Which is the better fit depends on your goals.
| MEDS | PZZA | |
|---|---|---|
Market Cap | 109.38B | 549.98B |
Volume | 60.43M | 336.9K |
Lot | 604.35K | 3.37K |
Turnover | 4.46B | 61.17M |
Average Price | 73.8 | 181.57 |
Value | 4.46B | 61.17M |
Indicative Equilibrium Price | 73 | 182 |
Indicative Equilibrium Volume | 12.68K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →PT Sarimelati Kencana Tbk. (the Company) was established based on Notarial Deed No. 132 dated December 16, 1987 of Lieke Lianadevi Tukgali, S.H.
Read more on PZZA →